Activase (alteplase) - Roche, Boehringer Ingelheim, Kyowa Kirin, Tanabe Pharma
Case Report: Ischemic stroke revealing carotid fibromuscular dysplasia with multiple metabolic disturbances in a 42-year-old man. (PubMed, Front Cardiovasc Med) - Sep 24, 2026 - "Intravenous thrombolysis with alteplase was administered within the therapeutic window...The coexistence of FMD with multiple metabolic disturbances in this case, while likely coincidental, underscores the complexity of stroke etiology and the importance of a comprehensive diagnostic approach that does not prematurely attribute stroke to common risk factors alone. Carotid FMD, though rare, is a treatable cause of stroke, and early diagnosis via DSA can guide appropriate management to prevent recurrence." 
Journal • Atherosclerosis • Cardiovascular • Diabetes • Dyslipidemia • Fibrosis • Hematological Disorders • Hypertriglyceridemia • Immunology • Ischemic stroke • Metabolic Disorders • Severe Hypertriglyceridemia
http://www.ncbi.nlm.nih.gov/pubmed/42774182
 
Min Li; Yinbao Hu
 
Sep 24, 2026
 
Prev Next